Equities
Health CareMedical Equipment and Services
  • Price (USD)203.20
  • Today's Change0.70 / 0.35%
  • Shares traded1.01k
  • 1 Year change-15.33%
  • Beta0.7360
Data delayed at least 15 minutes, as of Jul 03 2025 18:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.

  • Revenue in USD (TTM)23.82bn
  • Net income in USD3.77bn
  • Incorporated1986
  • Employees61.00k
  • Location
    Danaher Corp2200 Pennsylvania Ave NW Ste 800WWASHINGTON 20037-1731United StatesUSA
  • Phone+1 (202) 828-0850
  • Fax+1 (202) 828-0860
  • Websitehttps://www.danaher.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
DHR:NYQ since
announced
Transaction
value
Abdulla Fouad For Medical Supplies & Services Co-AFMS Business AssetsDeal completed30 Sep 202430 Sep 2024Deal completed-26.23%--
Data delayed at least 15 minutes, as of Jul 03 2025 18:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Medtronic PLC33.54bn4.66bn113.25bn95.00k24.442.3615.003.383.623.6226.0137.460.36922.175.31353,021.105.164.555.955.1565.3966.2513.9913.071.4211.190.371484.203.623.0126.82-0.27238.915.33
Danaher Corp23.82bn3.77bn145.42bn61.00k39.402.8623.756.115.165.1632.6271.060.29313.706.92390,491.804.635.915.096.5459.8059.4015.8119.381.0515.550.244714.68-0.06285.92-7.1710.5316.989.40
Stryker Corp23.22bn2.86bn151.06bn53.00k53.357.2238.536.517.417.4160.1754.780.54371.626.25438,075.506.696.648.117.9464.5763.8312.3113.020.9985--0.44544.0110.238.71-5.437.523.079.27
Boston Scientific Corp17.55bn2.03bn154.34bn53.00k76.476.9546.548.791.361.3611.7915.020.45712.027.03331,188.705.273.086.103.5768.7368.5111.547.780.88349.840.3350.0017.619.3018.0325.385.31--
Thermo Fisher Scientific Inc42.90bn6.52bn162.07bn125.00k25.193.2816.933.7817.0417.04112.23130.840.43744.864.47343,184.006.737.687.819.0241.3444.2415.3816.641.3824.800.40867.090.051310.925.6711.338.6215.48
Intuitive Surgical Inc8.71bn2.48bn195.15bn15.64k79.8611.4164.5122.396.826.8224.0147.730.49732.017.42557,289.9014.2312.3115.6113.7167.0967.3028.6226.113.97--0.000.0017.2413.2729.1810.9821.16--
Data as of Jul 03 2025. Currency figures normalised to Danaher Corp's reporting currency: US Dollar USD

Institutional shareholders

28.81%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202557.01m7.98%
BlackRock Fund Advisorsas of 31 Mar 202529.65m4.15%
SSgA Funds Management, Inc.as of 31 Mar 202527.46m3.84%
T. Rowe Price Associates, Inc. (IM)as of 31 Mar 202518.64m2.61%
Wellington Management Co. LLPas of 31 Mar 202517.07m2.39%
Capital Research & Management Co. (International Investors)as of 31 Mar 202515.06m2.11%
Geode Capital Management LLCas of 31 Mar 202513.64m1.91%
Fidelity Management & Research Co. LLCas of 31 Mar 202510.53m1.47%
Norges Bank Investment Managementas of 31 Dec 20249.28m1.30%
T. Rowe Price Investment Management, Inc.as of 31 Mar 20257.57m1.06%
More ▼
Data from 31 Dec 2024 - 31 Mar 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.